| Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? J Xu, A Turner, J Little, ER Bleecker, DA Meyers Human genetics 111, 573-574, 2002 | 284 | 2002 |
| CAS proteins in normal and pathological cell growth control N Tikhmyanova, JL Little, EA Golemis Cellular and molecular life sciences 67, 1025-1048, 2010 | 212 | 2010 |
| Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells JL Little, FB Wheeler, DR Fels, C Koumenis, SJ Kridel Cancer research 67 (3), 1262-1269, 2007 | 191 | 2007 |
| NEDD9 promotes oncogenic signaling in mammary tumor development E Izumchenko, MK Singh, OV Plotnikova, N Tikhmyanova, JL Little, ... Cancer research 69 (18), 7198-7206, 2009 | 144 | 2009 |
| Fatty acid synthase: a novel target for antiglioma therapy W Zhao, S Kridel, A Thorburn, M Kooshki, J Little, S Hebbar, M Robbins British journal of cancer 95 (7), 869-878, 2006 | 85 | 2006 |
| Cilia and cilia-associated proteins in cancer T Seeger-Nukpezah, JL Little, V Serzhanova, EA Golemis Drug Discovery Today: Disease Mechanisms 10 (3-4), e135-e142, 2013 | 58 | 2013 |
| Conditional expression of the mutant Ki- rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor … HS Floyd, CL Farnsworth, ND Kock, MC Mizesko, JL Little, ST Dance, ... Carcinogenesis 26 (12), 2196-2206, 2005 | 55 | 2005 |
| Fatty acid synthase activity in tumor cells JL Little, SJ Kridel Lipids in Health and Disease, 169-194, 2008 | 42 | 2008 |
| A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice JL Little, V Serzhanova, E Izumchenko, BL Egleston, E Parise, ... Oncogene 33 (4), 411-420, 2014 | 31 | 2014 |
| Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death JL Little, FB Wheeler, C Koumenis, SJ Kridel Molecular Cancer Therapeutics 7 (12), 3816-3824, 2008 | 21 | 2008 |
| Complete Genome Sequences of 12 B1 Cluster Mycobacteriophages, Gareth, JangoPhett, Kailash, MichaelPhcott, PhenghisKhan, Phleuron, Phergie, PhrankReynolds, PhrodoBaggins … KA Apellido, D Balchander, MC Erlich, JK Gocal, WA Gocal, S Haile, ... Microbiology Resource Announcements 8 (8), e01387-18, 2019 | | 2019 |
| Complete Genome Sequence of Cluster J Mycobacteriophage Superphikiman P Pradhan, S Nako, T Tran, LS Aluri, D Anandarajan, N Betini, SD Bhatt, ... Genome Announcements 6 (5), e01538-17, 2018 | | 2018 |
| A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice MF Ochs, JL Little, V Serzhanova, E Izumchenko, BL Egleston, E Parise, ... Nature Publishing Group, 2014 | | 2014 |
| A requirement for neural precursor cell-expressed developmentally downregulated gene 9 during the initiation of mammary tumorigenesis in MMTV-neu mice VA Serzhanova, JL Little, E Izumchenko, S Seo, M Kurokawa, B Egleston, ... CANCER RESEARCH 72, 2012 | | 2012 |
| Abstract P1-05-03: A requirement for neural precursor cell-expressed developmentally downregulated gene 9 during the initiation of mammary tumorigenesis in MMTV-neu mice VA Serzhanova, JL Little, E Izumchenko, S Seo, M Kurokawa, B Egleston, ... Cancer Research 72 (24_Supplement), P1-05-03-P1-05-03, 2012 | | 2012 |
| NEDD9 is required for initiation of HER2/Neu-dependent mammary tumor development JL Little, E Izumchenko, MK Singh, S Seo, M Kurokawa, BL Egleston, ... Cancer Research 70 (8_Supplement), 3257-3257, 2010 | | 2010 |
| Abstract# 2087: HEF1/NEDD9/CasL is required for activation of oncogenic signaling pathways in mammary tumor development E Izumchenko, O Plotnikova, M Singh, N Tikhmyanova, J Little, S Seo, ... Cancer Research 69 (9_Supplement), 2087-2087, 2009 | | 2009 |
| A Mechanistic Connection Between Fatty Acid Synthase and Endoplasmic Reticulum Homeostasis JL Little Wake Forest University, 2008 | | 2008 |
| ER stress upregulates the fatty acid synthesis pathway: implications for anti-tumor therapy J Little, F Wheeler, D Fels, C Koumenis, S Kridel Cancer Research 67 (9_Supplement), 4484-4484, 2007 | | 2007 |
| The Perk-eIF2α-ATF4 arm of the Unfolded Protein Response (UPR) contributes to tumor progression and is a target for therapeutic intervention. C Koumenis, M Bi, J Ye, D Fels, J Little, S Kridel Cancer Research 67 (9_Supplement), 4579-4579, 2007 | | 2007 |
